Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ) At $146.00 Forms Top; Marin Software (MRIN) Sentiment Is 0.61

August 27, 2017 - By Adrian Mccoy

Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ) formed multiple top with $151.84 target or 4.00% above today’s $146.00 share price. Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ) has $8.77 billion valuation. The stock decreased 1.56% or $2.32 on August 25, reaching $146. About 477,554 shares traded. Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) has risen 1.25% since August 27, 2016 and is uptrending. It has underperformed by 15.45% the S&P500.

Marin Software Incorporated provides a cross-channel, cross-device, enterprise marketing software platform for search, display and social advertising channels. The company has market cap of $43.50 million. The Company’s enterprise marketing software platform is offered as an integrated software-as-a-service solution for advertisers and agencies. It currently has negative earnings. The Company’s platform enables digital marketers to manage performance of their online advertising campaigns.

Investors sentiment increased to 0.95 in Q4 2016. Its up 0.27, from 0.68 in 2016Q3. It is positive, as 64 investors sold Jazz Pharmaceuticals plc – Ordinary Shares shares while 111 reduced holdings. 43 funds opened positions while 76 raised stakes. 50.81 million shares or 3.20% less from 52.49 million shares in 2016Q3 were reported. Caisse De Depot Et Placement Du Quebec has invested 0% in Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ). Alpine Woods Cap Ltd Liability owns 31,100 shares. First Quadrant Ltd Partnership Ca holds 0.14% or 62,038 shares in its portfolio. Brick & Kyle Assocs has 0.02% invested in Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ). Lincoln Natl Corporation stated it has 0.01% of its portfolio in Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ). Rhenman & Ptnrs Asset Ab reported 50,920 shares stake. Moreover, Neuberger Berman Lc has 0.02% invested in Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ). Federated Investors Inc Pa holds 0% or 10,000 shares. Eulav Asset Mgmt reported 63,000 shares. Balyasny Asset Mgmt Llc invested 0.15% of its portfolio in Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ). Aviance Cap Prtn Lc has 0.7% invested in Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ). Lazard Asset Mngmt Llc owns 0% invested in Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) for 15 shares. Lumina Fund Mngmt Limited Co accumulated 0.35% or 30,000 shares. Proshare Advsr Limited Liability Corp holds 0.05% or 40,426 shares. Fil holds 0.39% or 1.22M shares.

Since March 6, 2017, it had 0 insider buys, and 8 sales for $7.70 million activity. 200 shares were sold by MILLER MICHAEL PATRICK, worth $30,130 on Thursday, June 15. 2,500 shares were sold by Hooper Suzanne Sawochka, worth $400,000 on Tuesday, May 9. 884 shares valued at $116,666 were sold by Treacy Paul on Monday, March 6. On Thursday, June 1 the insider Winningham Rick E sold $750,000. COZADD BRUCE C had sold 30,000 shares worth $4.60 million on Thursday, May 11. Shares for $1.74M were sold by WILSON KAREN J.

Among 18 analysts covering Jazz Pharmaceuticals (NASDAQ:JAZZ), 14 have Buy rating, 0 Sell and 4 Hold. Therefore 78% are positive. Jazz Pharmaceuticals had 38 analyst reports since August 3, 2015 according to SRatingsIntel. The stock has “Hold” rating by H.C. Wainwright on Friday, August 25. The stock of Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) has “Buy” rating given on Wednesday, August 9 by Deutsche Bank. The firm has “Buy” rating by Deutsche Bank given on Thursday, August 11. The firm earned “Buy” rating on Thursday, July 27 by Cantor Fitzgerald. The stock of Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) has “Outperform” rating given on Wednesday, October 14 by Northland Capital. The stock of Jazz Pharmaceuticals plc – Ordinary Shares (NASDAQ:JAZZ) has “Buy” rating given on Wednesday, June 7 by Cowen & Co. As per Monday, June 6, the company rating was initiated by Goldman Sachs. Mizuho downgraded it to “Neutral” rating and $140 target in Tuesday, November 10 report. The company was maintained on Wednesday, February 24 by Stifel Nicolaus. Mizuho upgraded the stock to “Buy” rating in Wednesday, May 11 report.

The stock increased 4.76% or $0.05 on August 25, reaching $1.1. About 23,942 shares traded. Marin Software Inc (MRIN) has declined 39.81% since August 27, 2016 and is downtrending. It has underperformed by 56.51% the S&P500.